A detailed history of Richard Pzena (Pzena Investment Management LLC) transactions in United Therapeutics Corp stock. As of the latest transaction made, Pzena Investment Management LLC holds 1,599 shares of UTHR stock, worth $547,801. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,599
Previous 2,097 23.75%
Holding current value
$547,801
Previous $481,000 5.82%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$228.26 - $319.04 $113,673 - $158,881
-498 Reduced 23.75%
1,599 $509,000
Q1 2024

May 03, 2024

BUY
$210.76 - $249.51 $15,807 - $18,713
75 Added 3.71%
2,097 $481,000
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $34,165 - $40,853
159 Added 8.53%
2,022 $444,000
Q3 2023

Nov 09, 2023

SELL
$211.82 - $248.24 $44,694 - $52,378
-211 Reduced 10.17%
1,863 $420,000
Q2 2023

Aug 04, 2023

BUY
$205.19 - $232.99 $75,715 - $85,973
369 Added 21.64%
2,074 $457,000
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $363,147 - $470,869
1,705 New
1,705 $381,000
Q2 2022

Aug 05, 2022

SELL
$174.81 - $241.14 $483,874 - $667,475
-2,768 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$166.16 - $213.96 $30,074 - $38,726
181 Added 7.0%
2,768 $497,000
Q4 2021

Feb 04, 2022

SELL
$184.32 - $216.08 $38,522 - $45,160
-209 Reduced 7.47%
2,587 $559,000
Q3 2021

Nov 05, 2021

BUY
$179.86 - $214.88 $89,930 - $107,440
500 Added 21.78%
2,796 $516,000
Q2 2021

Aug 06, 2021

BUY
$170.47 - $211.93 $391,399 - $486,591
2,296 New
2,296 $412,000
Q1 2021

May 07, 2021

SELL
$153.94 - $174.85 $660,248 - $749,931
-4,289 Closed
0 $0
Q4 2020

Feb 05, 2021

SELL
$101.87 - $151.79 $81,903 - $122,039
-804 Reduced 15.79%
4,289 $651,000
Q3 2020

Oct 30, 2020

SELL
$99.9 - $121.13 $18,481 - $22,409
-185 Reduced 3.51%
5,093 $514,000
Q2 2020

Jul 31, 2020

BUY
$92.74 - $125.82 $489,481 - $664,077
5,278 New
5,278 $639,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track Richard Pzena's Portfolio

Track Richard Pzena Portfolio

Follow Richard Pzena (Pzena Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.